ConductScience.org, home
SK-HEP-1
API referenceFor AI assistants

Cell line · CVCL_0525

Papers83

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

1 to 20 of 83

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Multi-omics-driven personalized management of advanced HCC.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
USP4-Dependent CHAF1B Stabilization Regulates Distinct SETDB1 Ubiquitin States Linked to AKT T308 Signaling and Lipogenic Remodeling in HCC.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms.iScience2026Its Methods give the RRID and name the linePubMed
Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.iScience2026Its Methods give the RRID and name the linePubMed
Salmonella vector creates de novo parvovirus that reduces solid tumors and forms antitumor immune memory.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
IL-15 and IL-21 synergy improves anti-tumor efficacy of iPSC-derived cytotoxic T cells in solid tumors.Mol Ther2026Its Methods give the RRID and name the linePubMed
Synthesis of 2-Aryl(alkyl)benzimidazole Hydroxamic Acids as HDAC Inhibitors with Anti-Angiogenesis Properties.ChemMedChem2026Its Methods give the RRID and name the linePubMed
An SLCO2B1 mRNA Isoform Acts as a Noncoding RNA to Drive Cancer Progression by Triggering Protein Biosynthesis.Cancer Res2026Its Methods give the RRID and name the linePubMed
EP300 promotes hepatocellular carcinoma proliferation, migration and in vivo tumorigenicity revealed by integrated experimental and bioinformatic analyses.J Transl Med2026Its Methods give the RRID and name the linePubMed
TGFβ1 Activates Lnc-APUE to Promote Tumor Metastasis via the Alu Element-Driven STAU1-Mediated Decay of CDH1 mRNA.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
NAT10 drives hepatocellular carcinoma progression through SQLE-mediated cholesterol biosynthesis and is targetable by remodelin.iScience2026Its Methods give the RRID and name the linePubMed
Guaianolide dimer KGA-1002 targets GRP94 and triggers unfolded protein response-associated degradation of SKP2/AKT axis as a novel antihepatoma agent.J Adv Res2026Its Methods give the RRID and name the linePubMed
Dammarenediol II enhances etoposide-induced apoptosis by targeting O-GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Deep learning facilitated discovery of prognosis biomarkers and their ligands to improve liver cancer treatment.Int J Surg2026Its Methods give the RRID and name the linePubMed
Development of the FGFR4-ADC bearing the ferroptosis inducer sulfasalazine for hepatocellular carcinoma.iScience2025Its Methods give the RRID and name the linePubMed
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer models.EBioMedicine2025Its Methods give the RRID and name the linePubMed
Anti-Hepatocellular Carcinoma Effect of Jianpi Huayu Formula: Revealing the Molecular Mechanisms of the CXCR4 - Smad2/3 Pathway in Regulating Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition.
Integr Cancer Ther2025Its Methods give the RRID and name the linePubMed
Intracellular IL1α in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma.Cancer Res2025Its Methods give the RRID and name the linePubMed
Imaging and targeting S1PR1 in HER2+ tumors.Nucl Med Biol2025Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0525/papers

API referenceFor AI assistants